首页>
外国专利>
USE OF A CEA CD3 BISPECIFIC ANTIBODY AND A PD-1 AXIS BINDING ANTAGONIST IN A DOSAGE REGIME TO TREAT CANCER
USE OF A CEA CD3 BISPECIFIC ANTIBODY AND A PD-1 AXIS BINDING ANTAGONIST IN A DOSAGE REGIME TO TREAT CANCER
展开▼
机译:CEA CD3双特异性抗体和PD-1轴结合拮抗剂在治疗癌症剂量方案中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a PD-1 axis binding antagonist.
展开▼